Pathway to biosimilars is critical to industry, MBC tells NECN
July 30, 2009
MBC President & CEO Robert K. Coughlin and Timothy Hunt, Vice President of Public Affairs at Biogen Idec spoke with New England Cable News about the importance of a safe and effective pathway to biosimilars.
